Literature DB >> 12359505

Galanin overexpressing transgenic mice.

Jacqueline N Crawley1, Elliott J Mufson, John G Hohmann, Dawit Teklemichael, Robert A Steiner, Kristina Holmberg, Zhi-Qing D Xu, Karin Hygge Blakeman, Xiao-Jun Xu, Zsuzsanna Wiesenfeld-Hallin, Tamas Bartfai, Tomas Hökfelt.   

Abstract

Galanin overexpressing transgenic mice (GAL-tg) were generated on two different promoters. Both lines of GAL-tg displayed high levels of galanin in the hippocampus and reduced sensitivity to seizures, as compared to their respective wildtype littermate controls (WT). Performance deficits on learning and memory tasks, impaired long-term potentiation, reduced hippocampal excitability, lower evoked glutamate release, and reduced numbers of choline acetyltransferase immunoreactive neurons in the horizontal limb of the diagonal band were detected in GAL-tg as compared to WT. Changes in sensitivity to nociceptive stimuli were demonstrated in one line. GAL-tg represent a new model for investigating the biological actions of endogenous galanin, and for testing novel therapeutics based on galanin receptor ligands.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359505     DOI: 10.1054/npep.2002.0891

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  11 in total

1.  Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test.

Authors:  Takashi Yoshitake; Fu-Hua Wang; Eugenia Kuteeva; Kristina Holmberg; Masatoshi Yamaguchi; Jacqueline N Crawley; Robert Steiner; Tamas Bartfai; Sven Ove Ogren; Tomas Hökfelt; Jan Kehr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-30       Impact factor: 11.205

Review 2.  Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides.

Authors:  Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2007-03-30

Review 3.  Neuroprotective role for galanin in Alzheimer's disease.

Authors:  Scott E Counts; Sylvia E Perez; Stephen D Ginsberg; Elliott J Mufson
Journal:  Exp Suppl       Date:  2010

4.  Increased intake of ethanol and dietary fat in galanin overexpressing mice.

Authors:  Olga Karatayev; Jessica Baylan; Sarah F Leibowitz
Journal:  Alcohol       Date:  2009-12       Impact factor: 2.405

Review 5.  Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.

Authors:  J N Crawley
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 6.  Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

Authors:  S E Counts; S E Perez; E J Mufson
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

7.  Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior.

Authors:  Andrew Holmes; Qian Li; Elizabeth A Koenig; Eric Gold; Dejaimenay Stephenson; Rebecca J Yang; Jennifer Dreiling; Tim Sullivan; Jacqueline N Crawley
Journal:  Psychopharmacology (Berl)       Date:  2004-09-10       Impact factor: 4.530

Review 8.  Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.

Authors:  David Weinshenker; Philip V Holmes
Journal:  Brain Res       Date:  2015-11-20       Impact factor: 3.252

9.  Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism.

Authors:  Scott Davidson; Marissa Lear; Lynne Shanley; Benjamin Hing; Amanda Baizan-Edge; Annika Herwig; John P Quinn; Gerome Breen; Peter McGuffin; Andrew Starkey; Perry Barrett; Alasdair MacKenzie
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

10.  In the carotid body, galanin is a signal for neurogenesis in young, and for neurodegeneration in the old and in drug-addicted subjects.

Authors:  Andrea Mazzatenta; Guya D Marconi; Susi Zara; Amelia Cataldi; Andrea Porzionato; Camillo Di Giulio
Journal:  Front Physiol       Date:  2014-10-31       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.